|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7125 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 2928477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13861008.4 |
| Date of filing the European patent application | 2013-11-15 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation | 2019-10-10 |
| (86) | Number | PCT/US2013/070437 |
| Date | 2013-11-15 |
| (87) | Number | WO 2014/088785 |
| Date | 2014-06-12 |
| (30) | Number | Date | Country code |
| 201261734941 P | 2012-12-07 | US | |
| 201361799069 P | 2013-03-15 | US | |
| 201313841711 | 2013-03-15 | US | |
| 201361900347 P | 2013-11-05 | US |
| (72) |
STUART, Monic, J., US
KELSEY, Stephen, US
|
| (73) |
Geron Corporation,
919 E. Hillsdale Blvd., Foster City, CA 94404,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Telomerazės inhibitoriaus imetelstato panaudojimas mielofibrozės gydymui |
| USE OF THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOFIBROSIS |
| Payment date | Validity (years) | Amount | |
| 2024-09-26 | 12 | 289.00 EUR |
| 2025-11-15 |